NASDAQ:NYXH Nyxoah (NYXH) Stock Price, News & Analysis $8.40 +0.58 (+7.42%) (As of 08:34 AM ET) Add Compare Share Share Today's Range$8.40▼$8.4050-Day Range$6.87▼$11.0752-Week Range$4.00▼$20.00Volume6,733 shsAverage Volume50,217 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$17.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Nyxoah alerts: Email Address Nyxoah MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside111.9% Upside$17.80 Price TargetShort InterestHealthy0.38% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($1.72) to ($1.75) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.23 out of 5 stars 3.4 Analyst's Opinion Consensus RatingNyxoah has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNyxoah has only been the subject of 4 research reports in the past 90 days.Read more about Nyxoah's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.38% of the float of Nyxoah has been sold short.Short Interest Ratio / Days to CoverNyxoah has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nyxoah has recently decreased by 3.55%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldNyxoah does not currently pay a dividend.Dividend GrowthNyxoah does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NYXH. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Nyxoah this week, compared to 1 article on an average week. Previous Next N/A Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nyxoah insiders have not sold or bought any company stock.Read more about Nyxoah's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Nyxoah are expected to decrease in the coming year, from ($1.72) to ($1.75) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nyxoah is -5.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nyxoah is -5.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNyxoah has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Nyxoah's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. About Nyxoah Stock (NASDAQ:NYXH)Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.Read More NYXH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NYXH Stock News HeadlinesJuly 3, 2024 | globenewswire.comNyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment BankJuly 1, 2024 | globenewswire.comNyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDAJuly 8, 2024 | Porter & Company (Ad)Obama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” June 13, 2024 | investorplace.comHave $5-10? 7 Affordable Stocks That Are About to Breakout.June 3, 2024 | globenewswire.comNyxoah to Participate in the Jefferies Global Healthcare ConferenceJune 3, 2024 | globenewswire.comPublication relating to transparency notificationsMay 31, 2024 | globenewswire.comNyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional SharesMay 26, 2024 | uk.investing.comNyxoah shares target cut by H.C. Wainwright on capital raise dilutionJuly 8, 2024 | Porter & Company (Ad)Obama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” May 23, 2024 | marketwatch.comNyxoah Shares Drop 15% After Public Offering LaunchesMay 23, 2024 | globenewswire.comNyxoah Announces Pricing of OfferingMay 22, 2024 | globenewswire.comNyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering ProgramMay 22, 2024 | globenewswire.comNyxoah Announces Proposed Offering of Ordinary SharesMay 17, 2024 | uk.investing.comNyxoah stock price target cut, maintains Overweight on Q1 revenue reportMay 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Nyxoah Amidst Soaring Genio System Sales and Strategic PartnershipsMay 15, 2024 | markets.businessinsider.comCantor Fitzgerald Reaffirms Their Buy Rating on Nyxoah (NYXH)May 14, 2024 | investorplace.comNYXH Stock Earnings: Nyxoah Misses EPS, Beats Revenue for Q1 2024May 14, 2024 | finance.yahoo.comNyxoah Reports First Quarter 2024 Financial and Operating ResultsSee More Headlines Receive NYXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/07/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NYXH CUSIPN/A CIK1857190 Webwww.nyxoah.com Phone321-022-2355Fax321-045-9075Employees146Year FoundedN/APrice Target and Rating Average Stock Price Target$17.80 High Stock Price Target$20.00 Low Stock Price Target$15.00 Potential Upside/Downside+127.5%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-46,770,000.00 Net Margins-843.49% Pretax Margin-873.66% Return on Equity-42.14% Return on Assets-33.55% Debt Debt-to-Equity Ratio0.13 Current Ratio3.94 Quick Ratio3.70 Sales & Book Value Annual Sales$5.13 million Price / Sales38.05 Cash FlowN/A Price / Cash FlowN/A Book Value$5.08 per share Price / Book1.54Miscellaneous Outstanding Shares24,940,000Free FloatN/AMarket Cap$195.10 million OptionableNot Optionable Beta1.43 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Robert Taub MBA (Age 77)Co-Founder & Chairman Comp: $136.14kMr. Olivier Taelman (Age 52)CEO & Executive Director Comp: $673.23kMr. Loic Moreau (Age 43)Chief Financial Officer Comp: $338.16kMr. Bruno OnkelinxChief Technology OfficerMikaela KirkwoodCorporate Communication & Investor Relations ManagerMs. An MoonenGeneral CounselMr. Remi RenardVice President of Market & Market AccessMs. Inge VanwittenberghGlobal Human Resource DirectorMr. David M. DeMartinoChief Strategy OfficerMr. Jeyakumar SubbaroyanChief Clinical OfficerMore ExecutivesKey CompetitorsStevanato GroupNYSE:STVNLivaNovaNASDAQ:LIVNStrykerNYSE:SYKBoston ScientificNYSE:BSXBecton, Dickinson and CompanyNYSE:BDXView All CompetitorsInstitutional OwnershipDekaBank Deutsche GirozentraleSold 7,000 shares on 6/4/2024Ownership: 0.000%Opaleye Management Inc.Sold 24,800 shares on 5/29/2024Ownership: 0.000%Ikarian Capital LLCBought 50,699 shares on 5/17/2024Ownership: 0.000%Iron Triangle Partners LPBought 253,025 shares on 5/16/2024Ownership: 0.000%View All Institutional Transactions NYXH Stock Analysis - Frequently Asked Questions How have NYXH shares performed this year? Nyxoah's stock was trading at $4.64 at the start of the year. Since then, NYXH stock has increased by 81.0% and is now trading at $8.40. View the best growth stocks for 2024 here. How were Nyxoah's earnings last quarter? Nyxoah S.A. (NASDAQ:NYXH) released its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.45) EPS for the quarter, hitting the consensus estimate of ($0.45). The business had revenue of $1.33 million for the quarter, compared to analysts' expectations of $1.20 million. Nyxoah had a negative trailing twelve-month return on equity of 42.14% and a negative net margin of 843.49%. When did Nyxoah IPO? Nyxoah (NYXH) raised $83 million in an initial public offering on Friday, July 2nd 2021. The company issued 2,760,000 shares at a price of $30.00 per share. How do I buy shares of Nyxoah? Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NYXH) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. ...Stansberry Research | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
